The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(3-(3-(naphthalen-2-yl)pyridin-4-yl)acrylamido)propanoic acid ID: ALA4874386
PubChem CID: 164626764
Max Phase: Preclinical
Molecular Formula: C21H18N2O3
Molecular Weight: 346.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1
Standard InChI: InChI=1S/C21H18N2O3/c24-20(23-12-10-21(25)26)8-7-16-9-11-22-14-19(16)18-6-5-15-3-1-2-4-17(15)13-18/h1-9,11,13-14H,10,12H2,(H,23,24)(H,25,26)/b8-7+
Standard InChI Key: HOGGTKPOURHLCC-BQYQJAHWSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
39.1619 -6.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1607 -7.4478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9678 -7.7742 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5784 -7.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5756 -6.6247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8670 -6.2194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8645 -5.4022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1556 -4.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1532 -4.1786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4442 -3.7721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.2787 -6.2147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9883 -6.6224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2743 -5.4009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6906 -5.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6897 -6.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4087 -6.6246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1289 -6.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1258 -5.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4062 -4.9624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8596 -3.7679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9864 -4.9873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8572 -2.9507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5637 -2.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5613 -1.7228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2677 -1.3121 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.8523 -1.3163 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
11 12 2 0
12 15 1 0
14 21 1 0
21 13 2 0
13 11 1 0
5 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
9 20 1 0
20 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.39Molecular Weight (Monoisotopic): 346.1317AlogP: 3.51#Rotatable Bonds: 6Polar Surface Area: 79.29Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.08CX Basic pKa: 4.94CX LogP: 1.69CX LogD: -0.29Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.67Np Likeness Score: -0.28
References 1. Zhang H, Jing L, Liu M, Goto M, Lai F, Liu X, Sheng L, Yang Y, Yang Y, Li Y, Chen X, Lee KH, Xiao Z.. (2021) Identification of 3, 4-disubstituted pyridine derivatives as novel CDK8 inhibitors., 223 [PMID:34147745 ] [10.1016/j.ejmech.2021.113634 ]